Skip to main content
HEALIUS LIMITED logo

HEALIUS LIMITED — Investor Relations & Filings

Ticker · HLS ISIN · AU0000033359 LEI · 529900MBZK3SLWK8SJ55 ASX Human health and social work activities
Open in API
Filings indexed 2,292 across all filing types
Latest filing 2024-09-02 Share Issue/Capital Cha…
Country AU Australia
Listing ASX HLS

About HEALIUS LIMITED

https://www.healius.com.au

Healius Limited is a leading healthcare service provider specializing in pathology and diagnostic imaging services. The company operates an extensive network of pathology laboratories and collection centers, providing diagnostic testing across various medical disciplines including biochemistry, hematology, and microbiology. Its diagnostic imaging division offers a comprehensive range of services such as X-rays, ultrasounds, CT scans, and MRIs through a network of community-based and hospital-integrated clinics. Healius focuses on delivering high-quality diagnostic insights to healthcare professionals and patients, leveraging advanced technology and a large-scale infrastructure to support clinical decision-making and patient care outcomes.

Recent filings

Filing Released Lang Actions
Application for quotation of securities - HLS 7 pages 20.7KB
Share Issue/Capital Change Classification · 100% confidence The document is titled 'Appendix 2A - Application for quotation of securities' and is an announcement from Healius Limited regarding the application for quotation of securities issued under an employee incentive scheme. It details the number and type of securities to be quoted, issue dates, and related information. The document is a formal application to the ASX for listing additional securities and does not contain financial statements, management discussion, or other report content. It is a regulatory announcement related to capital market activities, specifically the quotation of securities. This fits the category of Share Issue/Capital Change (SHA), which covers announcements regarding new share issues or capital changes.
2024-09-02 English
Change of Director's Interest Notice 2 pages 229.3KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in securities holdings by a company director, including the number of shares held before and after the change, the nature of the change (vesting of share rights), and the value of the transaction. The document is short (3261 characters) and focuses solely on the director's personal share transactions. This matches the definition of 'Director's Dealing' filings, which report personal share transactions by company directors and executives (insider trades). There is no indication that this is a full financial report, management announcement, or other category. Therefore, the correct classification is DIRS.
2024-08-29 English
Change of Director's Interest Notice 2 pages 232.5KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details the change in securities holdings of a company director, including the number of shares held before and after the change, the nature of the change, and the value of the transaction. This is a report of personal share transactions by a company director, which fits the definition of 'Director's Dealing'. The document is not an announcement of a report, nor is it a full financial report or other type of filing. Therefore, the correct classification is DIRS.
2024-08-29 English
Becoming a substantial holder 28 pages 281.1KB
Major Shareholding Notification Classification · 95% confidence The document is a Form 603 Notice of Initial Substantial Holder filed under Corporations Law Section 671B. It details the substantial shareholding of UBS Group AG and its related bodies corporate in Healius Ltd, including voting power, relevant interests, registered holders, consideration paid, and associates. The document is regulatory in nature, reporting a change in significant share ownership levels. It does not contain financial statements, management discussion, or earnings data. It is not an announcement of a report but a formal notification of a major shareholding. Therefore, it fits the category of Major Shareholding Notification (MRQ). The document length and detail support a high confidence classification.
2024-08-21 English
Ceasing to be a substantial holder 3 pages 123.7KB
Major Shareholding Notification Classification · 100% confidence The document is titled 'Notice of ceasing to be a substantial holder' and references Form 605 under Corporations Law Section 671B. It details changes in relevant interests of UBS Group AG and its related bodies corporate in the voting securities of HEALIUS LIMITED, including dates, nature of changes (buy/sell), and number of securities affected. The document is a regulatory notice about shareholding changes, specifically the cessation of substantial shareholding. It does not contain financial statements, management discussion, or audit information. It is not an announcement of a report publication but a formal notification of shareholding status changes. This fits the definition of a Major Shareholding Notification (MRQ).
2024-08-21 English
Preliminary Final Report 30 pages 1.5MB
Annual Report Classification · 95% confidence The document is titled 'Appendix 4E – Preliminary Final Report (Unaudited)' for the year ended 30 June 2024, which is a regulatory filing format used in Australia for preliminary final reports. It contains detailed financial statements including consolidated profit or loss, comprehensive income, financial position, cash flows, and notes. The content includes extensive financial data, operational review, segment results, and cash flow analysis for the full fiscal year ending 30 June 2024. This matches the characteristics of an Annual Report or a full year financial report. Appendix 4E is typically a preliminary final report that serves as an annual report equivalent in Australian market practice. The document is not a short announcement or a certification letter but a comprehensive financial report with substantive financial data and analysis for the full fiscal year. Therefore, the appropriate classification is Annual Report (10-K equivalent). FY 2024
2024-08-20 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.